Competitive and/or technological threats are highlighted. Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Recent developments in the company covered in the profile help you track important events.Įquip yourself with information that enables you to sharpen your strategies and transform your operations profitably. The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Stay up to date on the major developments affecting the company.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. You get detailed information about the company and its operations to identify potential customers and suppliers. Key benefits of buying this profile include: Arens as Chief Financial Officer Jan 30,2019: Surmodics reports first quarter fiscal 2019 results Oct 31,2019: Surmodics reports fourth quarter fiscal 2019 results and issues fiscal 2020 revenue and EPS Guidance Jul 31,2019: Surmodics reports third quarter fiscal 2019 results and raises fiscal 2019 revenue and EPS guidance May 01,2019: Surmodics reports second quarter fiscal 2019 results Feb 18,2019: Surmodics names Timothy J. SurModics is headquartered in Eden Prairie, Minnesota, the US. The company produces and distributes surface coatings to the diagnostic and biomedical research markets. The company commercializes its technologies through license and royalty agreements with other medical device manufacturers. SurModics also sells components such as protein stabilizers, antigens, antibodies, surface coatings, and substrates for molecular tests and IVD immunoassays. The company offers a wide range of advanced balloon catheter, thrombectomy, surface modification coatings, and ultra-thin-walled catheter technologies to advance new medical devices, biomedical products, and enhance existing devices. SurModics Inc (SurModics) provides in vitro diagnostic (IVD) and medical device technologies to healthcare sector. Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history. Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company. Key operational heads - A list of personnel heading key departments/functions.
Executive biographies - A brief summary of the executives’ employment history. Key employees - A list of the key executives of the company. Key competitors - A list of key competitors to the company. Major products and services - A list of major products, services and brands of the company. Company history - Progression of key events associated with the company. SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats. Corporate strategy - Analyst’s summarization of the company’s business strategy. Business description - A detailed description of the company’s operations and business divisions. The profile contains critical company information including: The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. SurModics Inc (SRDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.